Browse Subject Areas

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Benefit from B-Lymphocyte Depletion Using the Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome. A Double-Blind and Placebo-Controlled Study

Table 4

SF-36 scores, baseline levels (0–100) and maximum changes (%) during follow-up, for patients in the Rituximab and Placebo groups.

Table 4